Bionest

Meet You at ASCO!

ASCO, the world’s largest meeting focused on cancer, is always one of the highlights of our calendar here at Bionest. This year is no exception and several of us are headed to Chicago for this year’s event, which is being held from May 31 to June 4. If you are going to ASCO, we’d love...

Bionest

Join Us at BIO for “Precision Medicine Beyond Oncology”

The original vision of “personalized medicine” focused on tailoring medications to the biology of the individual patient — treating them with the right drug at the right time. That view has since evolved beyond therapy selection to increasingly encompass aspects of drug discovery, planning and delivery of care, and patient engagement. This new approach, now...

Bionest

Innovation in HIV Therapies Improve Options for Care

Considerable progress has been made in the fight against HIV/AIDS since the first cases of the disease in the 1980s. Today, successful antiretroviral drug regimens are able to reduce viral loads to undetectable levels, cutting the risk of transmission almost to zero and effectively transforming AIDS into a chronic disease in many developed countries. However,...

Bionest

Virtual Reality Advances Aiding Surgical Education

Virtual reality, the simulation of an environment that a user can interact with, and augmented reality, the superimposition of computer-generated images and sounds onto the real world, have gained the widespread use in video games and 3-D movies. But surprisingly, these technologies have found a growing number of diverse applications in medicine as well.  ...

Bionest

Landmark Approvals in Depression

Depression is a challenging condition to treat. Most antidepressants take four to six weeks to take effect, and patient response to such drugs varies widely from person to person. As a result, most patients must try several drugs over a period of months before they can find relief. In March, the U.S. Food and Drug...